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f disease has been broken successfully, there remains a
rightening prospect of a future outbreak whichmay bemore
ontagious or virulent than ever encountered before.
Methods: Protein inhibitor of activated signal transducer
nd activator of transcription (STAT) 1(PIAS1) was identi-
ed in yeast two hybrid screens as an interacting partner
or STAT1. The interaction of N with PIAS1 was validated in
ammalian cells using co-immunoprecipitation.
Results: Our results of time-course based co-localisation
hows that the localization of N shifts from cytoplasmic to
uclear in presence of PIAS1. This, not only points towards
nteraction between N and PIAS1 but also one that is of major
hysiological consequence. PIAS1 acts as a key regulator of
K’B signaling pathway in the nucleus where it inhibits its
NA binding activity and NK’B mediated gene activation. NF-
B is a critical regulator of the immediate early pathogen
esponse, playing an important role in promoting inﬂamma-
ion and in the regulation of cell proliferation and survival.
ene activation analysis have shown that PIAS1 selectively
egulates a subset of NK’B dependent genes, with a notable
reference for proinﬂammatory cytokines and chemokines.
ere, we found that in presence of N, the inhibition induced
y PIAS1 to DNA binding activity of NF’B and NF’B medi-
ted gene activation is lifted. Not only that, our results
eveals that both DNA binding activity and NF’B mediated
ene activation is enhanced in presence of N.
Conclusion: We hypothesize that N translocates into
he nucleus where it, enhances the DNA binding activ-
ty of NF’B and NF’B mediated gene expression by lifting
p the inhibition imposed by PIAS1. Since many protein
roducts of the NF’B sensitive genes have been reported
o be upregulated in fatal clinical cases of SARS, we fur-
her hypothesize that N protein plays an important role in
xcessive expression/secretion of cytokines and chemokines
hereby contributing signiﬁcantly to the lung injury seen in
ases of SARS.
oi:10.1016/j.ijid.2010.02.666
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Background: Rhinovirus (Rhino) is one of the major
iruses of respiratory illness. There is a report that rhi-
oviruses had the highest prevalence among diseased cases
mong children under 5 years old who are hospitalized
y acute respiratory illness. The novel group of rhinovirus
rhino C) was found recently. However, details of epidemi-
logical features, including rhino C, in tropical climate are
till unknown. In this study, we tried to access the impor-
1
F
pternational Congress on Infectious Diseases (ICID) Abstracts
ance of rhinoviruses among severe respiratory infection of
hildren in the Philippines.
Methods: 816 nasopharyngeal swabs which were col-
ected from May 2008 to May 2009 from children (age: 7days
14years old) who were diagnosed as severe pneumonia were
sed.
RNA was extracted and subjected to RT-PCR targeting
’Non Coding Region and VP4/VP2 region. Sequencing analy-
is was carried out and rhinoviruses genogroups (A∼C) were
etermined.
Results: 243 out of 816 samples (30%) were positive for
hinoviruses. Among rhinoviruses positive samples, 131 (54%)
ere positive for rhino A, 25 (10%) were for rhino B, and
6 (35%) were for rhino C. The nucleotide sequence of Rhi-
ovirses (A,B,C) in VP4/VP2 showed that variable types of
hinovirus are co-circulating in one area, and were related
losely to the ones reported from various countries and year.
o etiological correlation was seen between any genogroups
r subspecies and severity. Rhinoviruses were detected all
he year.
However there was a peak for Rhino A in July to Septem-
er, Rhino B in September to November, and Rhino C in
ebruary to March. Rhinovirus infection in tropical zone may
ave different seasonality from the one in template zone
nd each genogroups may have different seasonality.
Conclusion: Rhinoviruses were detected with high preva-
ence among severe pneumonia which may suggest their
mportance among children in the Philippines.
oi:10.1016/j.ijid.2010.02.667
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Background: Viral diseases occupy 1-st place in infectious
athology and agents having pluripotent activity against dif-
erent viruses are welcomed. Previously, it was found that
errovir (FV) (sodium salt of DNA from salmon’s milt con-
ugated with Fe3+) possess antiviral activity against DNA-
nd RNA-viruses with lipid membrane: Herpes Simplex Virus
HSV), Cytomegalovirus (CMV), Human Immunodeﬁciency
irus (HIV), Tick-borne encephalitis virus, Human and Avian
nﬂuenza Virus in vitro studies. The mechanism of FV action
s connected with induction of inﬂammation cytokines and
ligopeptide antiviral factors. FV was effective in immuno-
ompromised patients (pts) with HIV-infection and Hepatitis
infection. The aim of the study was to analyze the efﬁ-
iency of FV against HSV-, CMV- and Human Papillomavirus
nfection (PVI).Methods: Clinical study enrolled 29 pts (15 female and
4 male) with recurrent genital HSVinfection who received
V 75mg once in 2 days as i/m injection for 20 days and 30
ts received standard therapy. Group of 11 pts (female) with
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hyperglycemia or organ (liver, brain or heart) damage. Early
intensive care must be considered in patients with these
initial poor prognostic factors.
doi:10.1016/j.ijid.2010.02.66914th International Congress on Infectious Diseases (ICID) Abs
reactivated and persistent CMVinfection received 75mg FV
twice daily for 10 days. Group of 63 pts with latent form of
PVI received course of FV of 10 injections every 72 hours.
Results: After FV treatment in 80% cases of pts with HSV-
infection not a single relapse was observed during 6 months,
lack of Ig M anti-HSV antibodies, negative cytological results.
In pts group with standard therapy of HSV-infection lack of
relapse was in 34% cases and in 50% cases in cytological sub-
strates HSV-1,2 was found. In 81,8% pts with CMV-infection
virus DNA in saliva, urine and cervical secret was not found
by PCR after treatment and 1 month later. FV treatment
resulted in 100% correction of immunological indices in
untreated previously PVI pts and 93,8% cases who previously
received therapy. 100% elimination of virus was observed in
newly treated pts and in 77,5% pts with previous therapy. FV
administration was well tolerated and no side effects were
observed.
Conclusion: Ferrovir demonstrated good antiviral proper-
tie, is well tolerated by patients, is useful in case of HSV-,
CMV and HPV-infection, and the low price makes it accessi-
ble to population in limited resources context.
doi:10.1016/j.ijid.2010.02.668
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Background: Echovirus 6 and echovirus 9 have been found
to cause deaths and critical infections in children but their
initial poor prognostic factors and clinical courses were not
well known.
Methods: Echovirus 6 or 9 was identiﬁed by immunoﬂuo-
rescent staining with virus-speciﬁc monoclonal antibody in
Initial
presentation of
patients
Percentage of severe cases
Cases with this
presentation
Cases wihou
presentation
Seizure with
initial
100 (2 2)* 2.3(4 172)
hyperglyremta (sugar>150mgdL)
Nivocarditis 100(11) 2.9(5.173)
AST> SOUL 50(24) 2.4(4 170)
ALT>45UL 100 (22) 2.3(4 172)
CRP>50mg 1 2.9(135) 3.6(5.139)
WBO15000 pi 3.5 (1,28) 3.4(5,146)
<3 monlh-old 6.1(233) 2.8(4141)cultures of children admitted in a tertiary hospital in Taiwan
from 2000 to 2008. The medical records of all cases without
any co-infection were extensively reviewed.
Clinical presentations of 6 severe cases (including those
were fatal, with intensive care or long-term sequel) andts e473
68 non-severe cases were analyzed. Initial prognostic fac-
ors were compared severe cases with non-severe cases by
isher’s exact test.
Results: Six children had severe clinical presentations.
wo children with echovirus 6 infections and one child with
chovirus 9 infection were fatal. They died of multi-organ
ailure, brain stem infarction and brain herniation, indi-
idually. One boy with echovirus 6 infection was rescued
y extra-corporeal membrane oxygenation (ECMO). All live
atients had full recovery except 2 children left long-term
equel of convulsion. Among 168 non-severe cases, the dis-
ase spectrums were similar for echovirus 6 (n = 96) and 9
n = 72) infections, with aseptic meningitis being the most
ommon syndrome, followed by meningismus, upper res-
iratory tract infection, pneumonia, and herpangina. The
nfavorable outcomes were more frequently encountered
n cases with initial presentations of seizure with hyper-
lycemia (serum glucose > 150mg/dl: p = 0.001), diagnosis
f myocarditis (p = 0.034), abnormal serum aspartate amino-
ransferase level (AST >80 U/l: p = 0.006), and higher serum
lanine transaminase level (ALT >45 U/l: p = 0.001), but did
ot correlate with C-reactive protein level (CRP >50mg/l:
= 0.653), white blood cell level (WBC level >15000 /ul:
= 0.657), or young age (<1 monthold: p = 0.444; < 3 month-
ld: p = 0.319; <6 month-old: p = 0.135) (Table 1).
Table 1 analysis on risk factors of severe eachovious 6 or
infection by comparing 6 severe cases with 168 non-severe
ases (p was calculated by Fisher exact test)
Odds ratio 95% conﬁdence
interval
P
44.0 16.7—1119
34.6 14.6-82.1 0.034
41.5 4.6-373.3 0.006
43.0 16.3-113.3 0.001
O.S 0.1-7.0 0.653
1.0 0.1-9.3 0.657
2.2 0.4-12.6 0.319
Percentage (Number of severe cases Total number of
ases in this condition).
Abbreviations: AST Aspartate aminotransferase; ALT Ala-
ine aminotransferase; CPJ5, C-reactive protein; WBC White
lood cell count.
Conclusion: Themost commonmanifestation of echovirus
and 9 infections in children was aseptic meningitis. Initial
iomarkers of poor prognostic factors, such as sugar, AST
nd ALT, are recommended to be checked. Fatal outcome or
ong term sequel in survivors may be encountered in young
hildren with speciﬁc presentations, including seizure with
